Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Abicipar pegol for wet age related macular degeneration	Abicipar pegol (AGN-150998)	Age-related macular degeneration (AMD)	Ophthalmology	2018	View \| Download
Anakinra for Still’s disease	Anakinra (Kineret)	Juvenile idiopathic arthritis	Rheumatology	2018	View \| Download
Angiotensin II acetate (Giapreza) for vasopressor resistant hypotension due to distributive shock	Angiotensin II acetate (Giapreza; LJPC-501)	Orthostatic hypotension	Cardiovascular System	2018	View \| Download
Apabetalone in addition to high-intensity statin therapy for preventing major adverse cardiac events in high-risk cardiovascular disease patients with type 2 diabetes mellitus	Apabetalone (RVX-208)	Major adverse cardiovascular events (MACE)	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Apalutamide in Addition to Abiraterone and Prednisone/Prednisolone for Metastatic Castration-resistant Prostate Cancer – First Line	Abiraterone acetate (Zytiga; Yonsa) , Apalutamide (Erleada; ARN-509) , Prednisone (Decadron; Lodotra)	Prostate cancer	Male Reproductive Cancer	2018	View \| Download
Apalutamide in addition to androgen deprivation therapy for metastatic hormone-sensitive prostate cancer	Apalutamide (Erleada; ARN-509)	Prostate cancer	Male Reproductive Cancer	2018	View \| Download
Apremilast for oral ulcers in active Beh cet’s disease	Apremilast (Otezla; CC-10004)	Oral ulcers	Dental and Oral Health	2018	View \| Download
AT406 (Debio 1143) for Ovarian Cancer – neoadjuvant therapy	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Xevinapant (Debio 1143; AT-406)	Ovarian cancer	Female Reproductive Cancer	2018	View \| Download
Atezolizumab in addition to Carboplatin or Cisplatin and Pemetrexed for Stage IV non-squamous non-small cell lung cancer (NSCLC)	Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Cisplatin (Platinol) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2018	View \| Download
Atezolizumab in addition to chemotherapy for small cell lung cancer – first line	Atezolizumab (Tecentriq; MPDL3280A)	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2018	View \| Download